The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions

Journal of the American Academy of Dermatology

Volumn 64, Issue 6, 2011, Pages 1085-1091

  Feldman, Steven R ^a   Tan, Jerry ^b   Poulin, Yves ^c   Dirschka, Thomas ^d   Kerrouche, Nabil ^e   Manna, Vasant ^e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Centre de Recherche Dermatologique du Quebec Metropolitain   (Canada)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e Galderma R and D   (France)

Author keywords

acne; adapalene; benzoyl peroxide; combination therapy; lesion; severity

Indexed keywords

ADAPALENE; ADAPALENE PLUS BENZOYL PEROXIDE; BENZOYL PEROXIDE;

ACNE VULGARIS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; GEL; HUMAN; INJECTION SITE BURNING; INJECTION SITE STINGING; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; SKIN DEFECT;

ACNE VULGARIS; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; MALE; NAPHTHALENES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79956101579     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.03.036     Document Type: Article

References (17)

1. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003;49(Suppl):S1-37.
2. Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004;14:4-12. (Pubitemid 38187090)
3. Tan JK, Fung K, Bulger L. Reliability of dermatologists in acne lesion counts and global assessments. J Cutan Med Surg 2006;10:160-5. (Pubitemid 351517516)
4. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol 2009;60(Suppl):S1-50.
5. Pochi PE, Shalita AR, Strauss JS, Webster SB. Report of the consensus conference on acne classification. J Am Acad Dermatol 1991;24:495-500.
6. US Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER). Guidance for industry; acne vulgaris: developing drugs for treatment. Available from: URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071292.pdf. Accessed September 2005.
7. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003;42:1287-304. (Pubitemid 37491489)
8. Brogden RN, Goa KL. Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997;53:511-9. (Pubitemid 27117366)
9. Michel S, Jomard A, Demarchez M. Pharmacology of adapalene. Br J Dermatol 1998;139(Suppl):3-7. (Pubitemid 28475276)
10. Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs 2004;64:1465-78. (Pubitemid 38980458)
11. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 2001;15(Suppl):51-5. (Pubitemid 34040987)
12. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracyclines and erythromycin. Antimicrob Agents Chemother 1982;21:770-2. (Pubitemid 12006526)
13. Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 2007;57:791-9. (Pubitemid 47553072)
14. Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1,670 patients. Br J Dermatol 2009;161:1180-9.
15. Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, et al. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis 2009;84:110-6.
16. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol 2007;6:899-905.
17. Tan JK, Balagurusamy M, Fung K, Gupta AK, Thomas DR, Sapra S, et al. The effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg 2009;13:204-8.